Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000040060 | SCV000063751 | uncertain significance | not specified | 2012-05-31 | criteria provided, single submitter | clinical testing | The Arg7678Gln variant in TTN has not been reported in the literature nor previo usly identified by our laboratory. Computational analyses (biochemical amino aci d properties, conservation, PolyPhen2, and SIFT) do not provide suport for or ag ainst an impact to the protein, though this information is not predictive enough to determine pathogenicity. Additional information is needed to fully assess th e clinical significance of the Arg7678Gln variant. |
Genetics and Genomics Program, |
RCV001293131 | SCV001434121 | likely benign | Primary dilated cardiomyopathy | criteria provided, single submitter | research | ||
Gene |
RCV001550107 | SCV001770388 | likely benign | not provided | 2018-07-03 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV001550107 | SCV004225895 | uncertain significance | not provided | 2022-03-21 | criteria provided, single submitter | clinical testing | BP4, PM2 |